Inventor
KETTENBERGER HUBERT
DE28 patents
⚠️ This page may combine multiple inventors who share the name “KETTENBERGER HUBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
23 patentsUS9714292B2Jul 25, 2017
Bispecific antibodies against human TWEAK and human IL17 and uses thereof
HOFFMANN LA ROCHE21 citations93
US9708396B2Jul 18, 2017
Bispecific anti-VEGF/anti-ANG-2 antibodies
HOFFMANN LA ROCHE16 citations92
US11286300B2Mar 29, 2022
Humanized anti-human CD19 antibodies and methods of use
HOFFMANN LA ROCHE11 citations85
US10822402B2Nov 3, 2020
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9862763B2Jan 9, 2018
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US10611825B2Apr 7, 2020
Monovalent antigen binding proteins
HOFFMANN LA ROCHE6 citations72
US10538585B2Jan 21, 2020
Anti-ANG2 antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US10465000B2Nov 5, 2019
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US9562091B2Feb 7, 2017
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations72
US10730938B2Aug 4, 2020
Bispecific antibodies and methods of use in ophthalmology
HOFFMANN LA ROCHE3 citations71
US12487245B2Dec 2, 2025
Antibody selection method
HOFFMANN LA ROCHE0 citations62
US12297263B2May 13, 2025
Humanized anti-Tau(PS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US12215152B2Feb 4, 2025
Humanized anti-human CD19 antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US11668722B2Jun 6, 2023
Antibody selection method
HOFFMANN LA ROCHE1 citations62
US11572404B2Feb 7, 2023
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US11866490B2Jan 9, 2024
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60
US11130804B2Sep 28, 2021
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60
US12103967B2Oct 1, 2024
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE0 citations56
US11739142B2Aug 29, 2023
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE1 citations56
US10793621B2Oct 6, 2020
Nucleic acid encoding dual Fc antigen binding proteins
HOFFMANN LA ROCHE0 citations51
US10047162B2Aug 14, 2018
Sequence dependent aggregation
HOFFMANN LA ROCHE0 citations50
US12461109B2Nov 4, 2025
Vitro prediction of in vivo half-life
HOFFMANN LA ROCHE0 citations46
US10418126B2Sep 17, 2019
Method for improving antibody stability
HOFFMANN LA ROCHE0 citations34